Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8913 | 0.94 | — | — | |
| Potassium SCHEMBL183183 | 0.89 | ALDH1A1 (0.42) | ALDH1A1TSHRTDP1 | |
| Lithium SCHEMBL775306 | 0.89 | ALDH1A1 (0.42) | ALDH1A1TSHRTDP1 | |
| SCHEMBL6504995 | 0.89 | TSHR (0.55) | ALDH1A1TSHRTDP1 | |
| SCHEMBL31678023 | 0.89 | ALDH1A1 (0.42) | ALDH1A1TSHRTDP1 | |
| Methane SCHEMBL30637 | 0.89 | ALDH1A1 (0.42) | ALDH1A1TSHRTDP1 | |
| Ethane SCHEMBL353672 | 0.89 | ALDH1A1 (0.42) | ALDH1A1TSHRTDP1 | |
| SCHEMBL30933076 | 0.89 | ALDH1A1 (0.42) | ALDH1A1TSHRTDP1 | |
| Water SCHEMBL8067978 | 0.89 | ALDH1A1 (0.42) | ALDH1A1TSHRTDP1 | |
| SCHEMBL15652979 | 0.89 | ALDH1A1 (0.42) | ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116462165-A | Preparation method of lithium bis (fluorosulfonyl) imide | 湖北兴发化工集团股份有限公司 | 2023-07-21 | — | — | CN | claimed |
| EP-3452465-B1 | SUBSTITUTED 2, 4-DIAMINO-QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES | GENOSCIENCE PHARMA (FR) | 2020-11-04 | — | — | EP | claimed |
| EP-3196185-B1 | ASYMMETRICAL HYDROGENATION REACTION OF KETONIC ACID COMPOUND | ZHEJIANG JIUZHOU PHARMA SCIENCE & TECH CO LTD (CN) | 2019-06-12 | — | — | EP | claimed |
| US-10112884-B2 | Asymmetrical hydrogenation reaction of ketonic acid compound | ZHEJIANG JIUZHOU PHARMA SCIENCE & TECH CO LTD (CN) | 2018-10-30 | — | — | US | claimed |
| US-20170260119-A1 | Asymmetrical hydrogenation reaction of ketonic acid compound | ZHEJIANG JIUZHOU PHARMA SCIENCE&TECHNOLOGY CO LTD (CN) | 2017-09-14 | — | — | US | claimed |
| EP-3196185-A1 | ASYMMETRICAL HYDROGENATION REACTION OF KETONIC ACID COMPOUND | Zhejiang Jiuzhou Pharma Science & Technology Co., Ltd. (CN) | 2017-07-26 | — | — | EP | claimed |
| WO-2003042148-A2 | PROCESS FOR PRODUCING BISBENZIL COMPOUNDS | SHOWA DENKO K. K. (JP) | 2003-05-22 | — | — | WO | claimed |
| WO-1993010076-A1 | SYNTHESIS AND OPTICAL RESOLUTION OF THE TAXOL SIDE CHAIN AND RELATED COMPOUNDS | THE UNIVERSITY OF MISSISSIPPI (US) | 1993-05-27 | — | — | WO | claimed |
| US-20260130872-A1 | Substituted Bicyclic Compounds, Compositions and Methods of Use | DEEP APPLE THERAPEUTICS, INC. (US) | 2026-05-14 | — | — | US | disclosed |
| EP-3854786-B1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | UBE CORP (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-20250326758-A1 | RICYCLIC HETEROARYL DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2025-10-23 | — | — | US | disclosed |
| EP-4061813-B1 | PYRROLIDINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2025-06-04 | — | — | EP | disclosed |
| US-20250129085-A1 | SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINES AS PROTEIN KINASE INHIBITORS | SUMITOMO PHARMA AMERICA INC (US) | 2025-04-24 | — | — | US | disclosed |
| US-12281074-B2 | Method for producing amino acid derivatives | UBE CORPORATION (JP) | 2025-04-22 | — | — | US | disclosed |
| WO-2002096858-A1 | CINNAMIDE DERIVATIVES AS KCNQ POTASSIUM CHANNEL MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-12-05 | — | — | WO | disclosed |
| EP-1208096-A1 | SUBSTITUTED PYRIDAZINES AND FUSED PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY | Bayer Corporation (US) | 2002-05-29 | — | — | EP | disclosed |
| WO-2001010859-A1 | SUBSTITUTED PYRIDAZINES AND FUSED PYRIDAZINES WITH ANGIOGENESIS INHIBITING ACTIVITY | BAYER CORPORATION (US) | 2001-02-15 | — | — | WO | disclosed |
| WO-1993010076-A1 | SYNTHESIS AND OPTICAL RESOLUTION OF THE TAXOL SIDE CHAIN AND RELATED COMPOUNDS | THE UNIVERSITY OF MISSISSIPPI (US) | 1993-05-27 | — | — | WO | disclosed |
| US-4107153-A | Heat-resistant thermosetting polyimide resin | TOSHIBA CHEMICAL PRODUCTS CO., LTD. (JP) | 1978-08-15 | — | — | US | disclosed |
| US-4097545-A | Heat-resistant thermosetting polyimide resin with bis-phenol-epichlorohydrin reaction product | TOSHIBA CHEMICAL PRODUCTS CO. LTD. (JA) | 1978-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260130872-A1 | Substituted Bicyclic Compounds, Compositions and Methods of Use | GIPR, GLP1R, SIGMAR1 | ALDH1A1 3287/4885TSHR 75/4885TDP1 3031/4885 |
| US-20250129085-A1 | SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINES AS PROTEIN KINASE INHIBITORS | PIM1, PIM2, PIM3 | ALDH1A1 3433/4885TSHR 956/4885TDP1 504/4885 |
| US-20170260119-A1 | Asymmetrical hydrogenation reaction of ketonic acid compound | KHK, PKLR, BCKDK | ALDH1A1 2109/4885TSHR 870/4885TDP1 4619/4885 |
| US-20250326758-A1 | RICYCLIC HETEROARYL DERIVATIVES | AR, CYP1B1, CYP1A1 | ALDH1A1 299/4885TSHR 2216/4885TDP1 3819/4885 |
| US-12281074-B2 | Method for producing amino acid derivatives | PTGS2, PTGES, PTGES2 | ALDH1A1 1057/4885TSHR 3320/4885TDP1 3836/4885 |
| US-10112884-B2 | Asymmetrical hydrogenation reaction of ketonic acid compound | KHK, PKLR, BCKDK | ALDH1A1 2109/4885TSHR 870/4885TDP1 4619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.